Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Doctors are prescribing the weight loss drug semaglutide ...

   www.aol.com/lifestyle/doctors-prescribing-weight...

   Given that people on other prescription weight-loss medications lose, on average, 3% to 12% of their body weight after a year, it’s not surprising that semaglutide’s results are leading some ...

3. As Ozempic craze grows and risks increase, FDA approves ... - AOL

   www.aol.com/ozempic-craze-grows-risks-increase...

   Wegovy was approved to target weight loss specifically, and individuals in clinical trials leading up to the approval saw a 6.2% loss of body weight on the drug, the FDA said.

4. What you should know about the latest obesity medication ...

   www.aol.com/news/obesity-medication-zepbound...

   The injectable medication Zepbound, manufactured by Eli Lilly, was approved by the FDA on November 8 to treat chronic obesity. - Eli Lilly/AP/FILE Wen: These medications both appear to work well.

5. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of ...

6. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   Orlistat was initially approved by the U.S. Food and Drug Administration in April 1999 as a prescription-only medication. [40] On 23 January 2006, an FDA advisory panel voted 11 to 3 to recommend the approval of an OTC formulation of orlistat, to be sold under the brand name Alli by GlaxoSmithKline. [41] Approval was granted on 7 February 2007 ...

7. FDA approves weight loss drug from Eli Lilly that helped ...

   www.aol.com/news/fda-approves-weight-loss-drug...

   The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months ...